Charles River Laboratories Acquires HemaCare Corporation

January 8, 2020

Charles River Laboratories Acquires HemaCare Corporation

Contract research organization, Charles River Laboratories has acquired HemaCare Corporation. The acquisition was completed at $380 million; HemaCare is a leading producer of human-derived cellular products for the cell therapy market. Yourway’s global, integrated depot network supports the transport of highly sensitive drugs and clinical trial material across borders.

Back to Index

Media

Upcoming Event

Clinical Trial Supply Europe

March 11-12, 2020
Madrid, Spain
Booth #54

Schedule a Meeting

Media

Articles

Agility and Flexibility in a Company That Provides Both Courier and Clinical Packaging Services